XML 99 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three-month periods ended March 31, 2024 and 2023, were as follows (in thousands):

    

Three Months Ended

    

March 31, 

    

2024

    

2023

Net sales

 

  

 

  

Cardiovascular

$

313,374

$

287,976

Endoscopy

 

10,134

 

9,589

Total net sales

 

323,508

 

297,565

Income from operations

 

  

 

  

Cardiovascular

 

32,907

 

23,934

Endoscopy

 

3,015

 

2,449

Total income from operations

 

35,922

 

26,383

Total other expense — net

 

(1,574)

 

(883)

Income tax expense

 

6,108

 

4,797

Net income

$

28,240

$

20,703